# VIA THERAPEUTICS, LLC: Development of dermal targeting formulations for squamous cell carcinoma

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | VIA THERAPEUTICS, LLC |
| Location | AUSTIN, TX |
| Project | Development of dermal targeting formulations for squamous cell carcinoma |
| Project number | 2R44CA257783-02A1 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $660,779 |
| Awarded | 2026-09-17 |
| Project period | 2021-07-12 to 2028-08-31 |
| UEI | YHRZATLXKL46 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11316113). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.